©2022 Stanford Medicine
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
Recruiting
I'm InterestedTrial ID: NCT03638427
Purpose
The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV
DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other
words, can the investigators detect the high risk strains of the human papilloma virus (HPV)
that are associated with cervical cancer in self-collected menstrual blood, as an alternative
to collecting vaginal swabs.
Official Title
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
Stanford Investigator(s)
Paul D. Blumenthal, MD, MPH
Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus
Eligibility
Inclusion Criteria:
There will be two study groups: 1) menstruating women over the age of 18 who have previous
history of HR-HPV in the last 18 months and 2) menstruating women over the age of 18 who do
not have a previous history of HR-HPV.
Exclusion Criteria:
- Women younger than 18 years old or are not menstruating regularly
Intervention(s):
diagnostic test: Menstrual Blood Analysis (Menstrual Blood Analysis)
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Klaira M Lerma, MPH
16507211562